Merck registers Phase 3 trial testing R-DXd maintenance in advanced ovarian cancerTrial updateDaiichi SankyoMerck & Co., Inc.
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyWeekly roundup, 5 itemsAstraZenecaAZD6489
AstraZeneca posts NATRON Phase III benralizumab results; registers ROSY-S anifrolumab rollover studyWeekly roundup, 9 itemsanifrolumab-fniaAstraZeneca
Sign inSign in